The primary mechanism of apatinib is to interfere with the binding of ATP with vascular endothelial growth factor receptor-2 and block the signal transduction after the VEGF combination, thus inhibiting tumor angiogenesis (Tian et al., 2011). The gene discussed is VEGFA; the disease is neoplasm.